Mounjaro Weight Loss Treatment in Miami, FL

Mounjaro is the brand name for tirzepatide, a dual-action GLP-1/GIP receptor agonist for weight management. Provider-supervised treatment at Femme Aesthetics in Miami.

Book a free consultation What it costs

5.0 on Google108 reviewsSouth Miami

Mounjaro tirzepatide weight loss treatment at Femme Aesthetics in Miami, FL

Procedure: Weekly Injection
Results Visible: 4 – 8 Weeks
Program: Ongoing
Downtime: None

What Is Mounjaro?

Mounjaro is the brand name for tirzepatide, an injectable prescription medication manufactured by Eli Lilly. Originally FDA-approved for type 2 diabetes, tirzepatide has demonstrated remarkable efficacy for weight management and is widely prescribed off-label for medical weight loss. Zepbound is the weight-loss-specific brand of the same active ingredient.

What makes Mounjaro unique is its dual-action mechanism. Unlike semaglutide-based medications such as Ozempic and Wegovy — which target only the GLP-1 receptor — Mounjaro activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. This dual targeting provides enhanced appetite suppression, improved blood sugar regulation, and greater weight loss potential compared to single-agonist medications.

In head-to-head clinical trials, patients on tirzepatide achieved average weight loss of up to 22.5% of their body weight at the highest dose, compared to approximately 15% with semaglutide. At Femme Aesthetics, our medical providers evaluate each patient individually to determine whether Mounjaro is the right fit for their weight loss goals.

Why Choose Mounjaro

Benefits of Mounjaro for Weight Loss

01Up to 22.5% Body Weight LossClinical trials have shown that patients on the highest dose of tirzepatide lost up to 22.5% of their body weight, making it one of the most effective weight loss medications available.
02Dual Hormone TargetingMounjaro activates both GLP-1 and GIP receptors, providing a more comprehensive approach to appetite regulation and metabolic improvement than single-agonist medications.
03Appetite RegulationBy mimicking two satiety hormones, Mounjaro significantly reduces hunger and food cravings, making it easier to maintain a caloric deficit without constant willpower.
04Metabolic Health ImprovementBeyond weight loss, Mounjaro helps regulate blood sugar levels and improve insulin sensitivity, making it especially beneficial for patients with metabolic syndrome or pre-diabetes.
05Convenient Weekly InjectionMounjaro is administered as a simple once-weekly subcutaneous injection. We teach you how to self-administer at home during your first visit for maximum convenience.
06Medical SupervisionRegular check-ins with our clinical team ensure your safety, allow for dosage adjustments, and provide ongoing support throughout your weight loss journey.

How Mounjaro Works

Mounjaro’s active ingredient, tirzepatide, is a dual GLP-1/GIP receptor agonist. This means it simultaneously activates two key hormonal pathways involved in appetite and metabolism:

GLP-1 (Glucagon-Like Peptide-1): Slows gastric emptying so you feel full longer, reduces appetite signals in the brain, and helps regulate blood sugar by stimulating insulin release after meals.
GIP (Glucose-Dependent Insulinotropic Polypeptide): Enhances the body’s insulin response, supports fat metabolism, and works synergistically with GLP-1 to amplify appetite suppression and improve energy balance.

By targeting both receptors, Mounjaro delivers a more comprehensive metabolic effect than single-action GLP-1 medications like semaglutide. The dual mechanism helps patients achieve greater weight loss, better blood sugar control, and more sustainable appetite regulation.

The medication is injected subcutaneously (under the skin) once per week, typically in the abdomen, thigh, or upper arm. Dosing begins low and is gradually escalated over several weeks to minimize gastrointestinal side effects and allow the body to adjust.

Your Visit

What to Expect

i
Before Treatment

Consultation & Evaluation
Your Mounjaro journey begins with a comprehensive initial consultation. Our clinical team will conduct a thorough health assessment to determine if tirzepatide is the right medication for you.
- Complete health assessment and review of medical history
- Lab work and blood panel to evaluate metabolic health
- BMI evaluation and body composition analysis
- Discussion of your weight loss goals and expectations
- Review of current medications and potential interactions
- Comparison of Mounjaro vs. semaglutide options based on your profile
During Treatment

Dosing & Escalation Schedule

Mounjaro treatment begins at 2.5 mg per week for the first four weeks. The dose is then gradually increased in 2.5 mg increments every four weeks, up to a maximum of 15 mg, based on your tolerance and clinical response. This careful escalation minimizes side effects while optimizing weight loss. During your first visit, we teach you how to self-administer the injection at home using the pre-filled pen.
iii
After Treatment

Ongoing Monitoring & Results
Regular follow-up appointments ensure your progress is on track and allow our medical providers to adjust your care as needed. Most patients begin seeing measurable results within 4 to 8 weeks.
- Regular weigh-ins and progress assessments
- Dosage adjustments based on response and tolerance
- Side effect monitoring and management
- Lifestyle and nutritional guidance to complement medication
- Long-term maintenance planning to sustain your results

Possible Side Effects

The most common side effects of Mounjaro (tirzepatide) include nausea (especially during dose escalation), diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach pain. These gastrointestinal symptoms are typically mild to moderate and tend to diminish as the body adjusts to the medication over the first few weeks.

Less common but more serious side effects may include pancreatitis, gallbladder problems, hypoglycemia (especially when combined with other diabetes medications), and allergic reactions. Mounjaro carries a boxed warning regarding the risk of thyroid C-cell tumors observed in animal studies, though this has not been confirmed in humans.

Our clinical team monitors you closely throughout the program, adjusts dosing to minimize discomfort, and provides guidance on managing any side effects you may experience.

Transparent Pricing

What this costs

Mounjaro is a brand name for tirzepatide, which is what we dispense and how it is priced — by the volume, which tracks the dose you titrate up to. Your first consultation is complimentary.

Tirzepatide 2ml–8ml$500–$1,365

Prices vary with how much product a treatment plan calls for and which areas are treated. See the full menu on our pricing page, or book a consultation and we will quote you before anything begins.

See every price

Have Questions?

Frequently Asked Questions About Mounjaro

Every question we’ve been asked

What is Mounjaro?

Mounjaro is the brand name for tirzepatide, a prescription medication manufactured by Eli Lilly. It is an FDA-approved dual-action GLP-1/GIP receptor agonist that was originally developed for type 2 diabetes and has shown significant results for weight management. It works by targeting two gut hormones simultaneously to reduce appetite, slow gastric emptying, and improve metabolic function.

How is Mounjaro different from Ozempic or Wegovy?

Mounjaro (tirzepatide) targets both GLP-1 and GIP receptors, while Ozempic and Wegovy (semaglutide) target only the GLP-1 receptor. This dual-action mechanism is what sets Mounjaro apart. In head-to-head clinical trials, tirzepatide demonstrated greater average weight loss than semaglutide, with patients losing up to 22.5% of their body weight compared to approximately 15% with semaglutide.

How much weight can I lose with Mounjaro?

Results vary by individual, but clinical trials have shown that patients using tirzepatide (the active ingredient in Mounjaro) lost up to 22.5% of their body weight at the highest dose. Factors such as starting weight, diet, physical activity, and adherence to the program all influence individual outcomes. Our medical providers will set realistic expectations during your consultation.

Is Mounjaro the same as tirzepatide?

Yes. Mounjaro is the brand name for tirzepatide, manufactured by Eli Lilly. Tirzepatide is the active pharmaceutical ingredient. Zepbound is another brand name for tirzepatide that is specifically FDA-approved for weight management, while Mounjaro is FDA-approved for type 2 diabetes but is widely used off-label for weight loss.

How much does Mounjaro cost?

The cost of Mounjaro treatment varies depending on dosage, program duration, and whether insurance covers any portion. Many insurance plans do not cover GLP-1 medications prescribed specifically for weight loss. During your consultation at Femme Aesthetics, our team will discuss pricing, payment options, and help you understand the financial aspects of your treatment plan.

How long do I need to take Mounjaro?

Treatment duration varies by patient. Most patients remain on Mounjaro for several months to over a year, depending on their weight loss goals and clinical response. Discontinuing too early can lead to weight regain, so our medical providers will work with you to determine the appropriate timeline and develop a long-term maintenance strategy.

Ready to Start Mounjaro?

Schedule a personalized consultation at Femme Aesthetics to find out if Mounjaro (tirzepatide) is right for your weight loss goals. Our medical providers will evaluate your health and create a program tailored to you.

Book a free consultation Call (786) 250-4133

In English or Spanish, whichever you’d rather.

Explore More